Results will be good. Everyone and everything will, as a result, want to move ahead fast.
But they dont have enough money to pay for accelerating the USA adult trial, nor the cost of consultants handling TGA, CE and FDA approvals for both Resapp and the sleep apnoea products.
Moreover they need to put on staff to handle the incoming customers and set up systems
Everything would slow down for 6 months until, post FDA when commercial sales began to provide funds.
Some great offer has been made which was too good to resist.
Fox
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-52
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online